PARNAX LAB LTD. (PARNAXLAB) financials

PARNAX LAB LTD. (PARNAXLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Market Cap: ₹127Cr.
Current Price: ₹111
Stock P/E: 83.0
ROE: 4.00%
ROCE: 3.09%
Book Value: ₹20.4
Dividend Yield: 0.00%
52W High / Low: ₹182/99.2

In Jun 2026, PARNAX LAB LTD. (PARNAXLAB) reported sales ₹2.57 Cr and net profit ₹0.85 Cr.

Annual TTM: sales ₹7.23 Cr, net profit ₹1.50 Cr.

Shareholding: Promoters 72.30% (Jun 2026), Public 27.71% (Jun 2026), No. of Shareholders 3,572% (Jun 2026).

PARNAXLAB quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	1.54	0.99	0.84	1.97	1.70	2.71	0.25	2.57
Expenses	1.34	0.93	1.12	1.82	1.20	1.94	3.25	1.91
Operating Profit	0.20	0.06	-0.28	0.15	0.50	0.77	-3.00	0.66
OPM %	12.99%	6.06%	-33.33%	7.61%	29.41%	28.41%	-1,200.00%	25.68%
Other Income	0.18	0.17	0.19	0.19	0.20	0.20	1.75	0.21
Interest	0.00	0.01	0.01	0.01	0.02	0.00	0.01	0.00
Depreciation	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Profit before tax	0.36	0.20	-0.12	0.31	0.66	0.95	-1.28	0.85
Tax %	25.00%	25.00%	-25.00%	25.81%	25.76%	25.26%	-57.03%	0.00%
Net Profit	0.27	0.16	-0.08	0.23	0.49	0.71	-0.55	0.85
EPS in Rs	0.24	0.14	-0.07	0.20	0.43	0.62	-0.48	0.74
Raw PDF	—	—	—	—	—	—	—	—

PARNAXLAB profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	7.68	2.37	7.15	7.47	7.44	7.02	6.63	7.23
Expenses	7.15	2.82	5.78	5.90	5.33	5.79	8.23	8.30
Operating Profit	0.53	-0.45	1.37	1.57	2.11	1.23	-1.60	-1.07
OPM %	6.90%	-18.99%	19.16%	21.02%	28.36%	17.52%	-24.13%	-14.80%
Other Income	0.42	0.07	0.16	0.37	0.54	0.71	2.34	2.36
Interest	1.38	0.83	0.71	0.25	0.14	0.02	0.03	0.03
Depreciation	0.04	0.04	0.04	0.07	0.06	0.06	0.06	0.08
Profit before tax	-0.47	-1.25	0.78	1.62	2.45	1.86	0.65	1.18
Tax %	325.53%	-9.60%	30.77%	25.93%	25.31%	24.73%	-36.92%	—
Net Profit	-2.00	-1.13	0.54	1.20	1.82	1.39	0.89	1.50
EPS in Rs	-2.35	-1.33	0.55	1.04	1.58	1.21	0.77	1.31
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

PARNAXLAB balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8.50	8.50	8.50	9.81	11.49	11.49	11.49	11.49
Reserves	-0.68	-2.68	-3.79	2.94	7.87	9.67	11.06	11.93
Borrowings	11.23	11.06	11.41	9.20	1.07	0.00	0.00	0.00
Other Liabilities	1.36	1.77	1.52	1.58	0.94	1.08	2.17	1.18
Total Liabilities	20.41	18.65	17.64	23.53	21.37	22.24	24.72	24.60
Fixed Assets	0.57	0.53	0.49	0.44	0.43	0.49	0.43	0.39
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	10.07	10.07	10.07	10.07	10.03	10.03	10.03	10.03
Other Assets	9.77	8.05	7.08	13.02	10.91	11.72	14.26	14.18
Total Assets	20.41	18.65	17.64	23.53	21.37	22.24	24.72	24.60

PARNAXLAB cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	1.68	2.20	0.47	-0.36	-0.28	0.08	0.28	-0.72
Cash from Investing Activity	0.03	-0.01	0.00	0.00	0.14	0.30	-0.19	0.57
Cash from Financing Activity	-2.25	-1.55	-0.48	4.59	-2.92	-1.21	-0.02	-0.03
Net Cash Flow	-0.55	0.64	-0.01	4.23	-3.07	-0.83	0.06	-0.18
Free Cash Flow	1.76	2.18	0.47	-0.36	-0.33	0.16	0.34	-0.75
CFO/OP	1,464%	411%	-104%	-26%	-17%	4%	24%	44%

PARNAXLAB shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	72.30%	72.30%	72.30%	72.30%	72.30%	72.30%	72.30%	72.30%
Public	27.71%	27.71%	27.70%	27.70%	27.71%	27.70%	27.71%	27.71%
No. of Shareholders	4,173	4,521	4,440	4,317	4,111	3,900	3,721	3,572

PARNAXLAB key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	140.60	97.90	66.22	94.95	52.77	28.94	44.20	23.12
Inventory Days	47.76	12.70	145.00	84.81	60.83	108.77	94.58	96.05
Days Payable	98.93	88.07	285.00	122.38	45.10	85.81	162.49	52.83
Cash Conversion Cycle	89.43	22.53	-73.78	57.38	68.50	51.91	-23.71	66.35
Working Capital Days	191.22	-153.03	-840.89	-297.10	164.67	319.87	399.32	535.11
ROCE %	2.84%	5.07%	-2.55%	7.83%	8.82%	12.45%	8.60%	3.09%

PARNAXLABUpdated 30 Sept 2026, 18:37

Parnax Lab Ltd.

PARNAXLABUpdated 30 Sept 2026, 18:37

Market Cap

₹127Cr.

Current Price

₹111

High / Low

₹182/99.2

Stock P/E

83.0

ROE4.00%

ROCE3.09%

Book Value₹20.4

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	1.13	0.04	1.1	0.11	0.01	0.09	22.22	0.07	0.06
Sep 2023	1.83	0.07	1.13	0.18	0.02	0.79	24.05	0.6	0.52
Dec 2023	2.77	0.01	1.54	0.12	0.01	1.33	25.56	0.99	0.86
Mar 2024	1.71	0.02	1.54	0.11	0.01	0.25	28	0.17	0.15
Jun 2024	3.66	0.01	2.4	0.17	0.02	1.4	25	1.05	0.91
Sep 2024	1.54	0	1.34	0.18	0.02	0.36	25	0.27	0.24
Dec 2024	0.99	0.01	0.93	0.17	0.02	0.2	25	0.16	0.14
Mar 2025	0.84	0.01	1.12	0.19	0.02	-0.12	-25	-0.08	-0.07
Jun 2025	1.97	0.01	1.82	0.19	0.02	0.31	25.81	0.23	0.2
Sep 2025	1.7	0.02	1.2	0.2	0.02	0.66	25.76	0.49	0.43
Dec 2025	2.71	0	1.94	0.2	0.02	0.95	25.26	0.71	0.62
Mar 2026	0.25	0.01	3.25	1.75	0.02	-1.28	-57.03	-0.55	-0.48
Jun 2026	2.57	0	1.91	0.21	0.02	0.85	0	0.85	0.74

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	15.86	1.41	16.19	0.78	0.8	-1.76	-31.82	-1.2	-1.41
Mar 2016	7.12	1.09	7.52	0.66	0.6	-1.43	-28.67	-1.01	-1.19
Mar 2017	5.28	1.33	4.66	0.28	0.53	-0.96	-30.21	-0.67	-0.79
Mar 2018	5.8	1.28	6.68	0.13	0.44	-2.47	-3.24	-2.4	-2.82
Mar 2019	6.49	1.08	6.38	0.51	0.05	-0.51	62.75	-0.83	-0.98
Mar 2020	7.68	1.38	7.15	0.42	0.04	-0.47	325.53	-2	-2.35
Mar 2021	2.37	0.83	2.82	0.07	0.04	-1.25	-9.6	-1.13	-1.33
Mar 2022	7.15	0.71	5.78	0.16	0.04	0.78	30.77	0.54	0.55
Mar 2023	7.47	0.25	5.9	0.37	0.07	1.62	25.93	1.2	1.04
Mar 2024	7.44	0.14	5.33	0.54	0.06	2.45	25.31	1.82	1.58
Mar 2025	7.02	0.02	5.79	0.71	0.06	1.86	24.73	1.39	1.21
Mar 2026	6.63	0.03	8.23	2.34	0.06	0.65	-36.92	0.89	0.77
TTM	7.23	0.03	8.3	2.36	0.08	1.18	—	1.5	1.31

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	72.3%
Public	27.71%

Shareholding trend

Ownership over time%

Quarter	Promoters	Public
Sep 2023	72.3%	27.69%
Dec 2023	72.3%	27.7%
Mar 2024	72.3%	27.7%
Jun 2024	72.3%	27.7%
Sep 2024	72.3%	27.71%
Dec 2024	72.3%	27.71%
Mar 2025	72.3%	27.7%
Jun 2025	72.3%	27.7%
Sep 2025	72.3%	27.71%
Dec 2025	72.3%	27.7%
Mar 2026	72.3%	27.71%
Jun 2026	72.3%	27.71%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	Investments	Other Assets	Total Assets
Mar 2015	8.5	4.12	18.9	3.65	35.17	7.28	10.71	17.18	35.17
Mar 2016	8.5	3.1	16.91	1.75	30.26	6.69	10.71	12.86	30.26
Mar 2017	8.5	2.48	12.12	1.73	24.83	6.36	10.13	8.34	24.83
Mar 2018	8.5	0.15	12.4	2.11	23.16	0.62	10.02	12.52	23.16
Mar 2019	8.5	-0.68	11.23	1.36	20.41	0.57	10.07	9.77	20.41
Mar 2020	8.5	-2.68	11.06	1.77	18.65	0.53	10.07	8.05	18.65
Mar 2021	8.5	-3.79	11.41	1.52	17.64	0.49	10.07	7.08	17.64
Mar 2022	9.81	2.94	9.2	1.58	23.53	0.44	10.07	13.02	23.53
Mar 2023	11.49	7.87	1.07	0.94	21.37	0.43	10.03	10.91	21.37
Mar 2024	11.49	9.67	0	1.08	22.24	0.49	10.03	11.72	22.24
Mar 2025	11.49	11.06	0	2.17	24.72	0.43	10.03	14.26	24.72
Mar 2026	11.49	11.93	0	1.18	24.6	0.39	10.03	14.18	24.6

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	-2.09	-0.08	2.33	0.17
Mar 2016	1.78	0	-1.98	-0.2
Mar 2017	3.67	0.34	-3.78	0.23
Mar 2018	0.64	0.12	-1	-0.24
Mar 2019	1.68	0.03	-2.25	-0.55
Mar 2020	2.2	-0.01	-1.55	0.64
Mar 2021	0.47	0	-0.48	-0.01
Mar 2022	-0.36	0	4.59	4.23
Mar 2023	-0.28	0.14	-2.92	-3.07
Mar 2024	0.08	0.3	-1.21	-0.83
Mar 2025	0.28	-0.19	-0.02	0.06
Mar 2026	-0.72	0.57	-0.03	-0.18

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	249.47	382.94	233.66	254.24	140.60	97.90	66.22	94.95	52.77	28.94	44.20	23.12
Inventory Days	50.63	28.42	36.10	55.02	47.76	12.70	145.00	84.81	60.83	108.77	94.58	96.05
Days Payable	72.93	32.86	97.60	173.11	98.93	88.07	285.00	122.38	45.10	85.81	162.49	52.83
Cash Conversion Cycle	227.17	378.50	172.15	136.15	89.43	22.53	-73.78	57.38	68.50	51.91	-23.71	66.35
Working Capital Days	170.99	203.52	-137.57	213.97	191.22	-153.03	-840.89	-297.10	164.67	319.87	399.32	535.11
ROCE %	-1.13%	-1.13%	1.43%	-4.39%	2.84%	5.07%	-2.55%	7.83%	8.82%	12.45%	8.60%	3.09%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of PARNAX LAB LTD. (PARNAXLAB)?

The reported market capitalisation for PARNAX LAB LTD. (PARNAXLAB) is ₹127Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of PARNAXLAB?

The current price shown for PARNAX LAB LTD. (PARNAXLAB) on Fincrux is ₹111 with a 52-week high/low of ₹182/99.2.

What is the P/E ratio of PARNAX LAB LTD. (PARNAXLAB)?

The stock P/E for PARNAX LAB LTD. (PARNAXLAB) is 83.0 on Fincrux, with ROE at 4.00% and ROCE at 3.09%.

What were PARNAXLAB latest quarterly results?

For Jun 2026, PARNAX LAB LTD. (PARNAXLAB) reported sales ₹2.57 Cr and net profit ₹0.85 Cr (figures in ₹ crore unless noted).

What are PARNAXLAB annual sales and net profit?

For TTM, PARNAX LAB LTD. (PARNAXLAB) shows sales of ₹7.23 Cr and net profit of ₹1.50 Cr on the Fincrux profit & loss statement.

Who owns PARNAX LAB LTD. (PARNAXLAB)?

Latest shareholding for PARNAX LAB LTD. (PARNAXLAB) on Fincrux: Promoters 72.30% (Jun 2026), Public 27.71% (Jun 2026), No. of Shareholders 3,572% (Jun 2026).

Where can I find PARNAX LAB LTD. (PARNAXLAB) financials?

PARNAX LAB LTD. (PARNAXLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show PARNAXLAB balance sheet and cash flow?

Yes. The PARNAX LAB LTD. (PARNAXLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 30 September 2026 at 18:37